Market & Industry Briefs
Executive Summary
Brief summaries of recent medtech market and industry developments. This month we cover recent device M&A, Medtronic and Nile Therapeutics' collaboration in heart failure, Neoprobe and Naviscan PET Systems' deal in cancer detection, and Qiagen and Epigenomics AG's collaboration in a blood test for colorectal cancer.
You may also be interested in...
Market & Industry Briefs
Brief summaries of recent medtech market and industry developments. This month we cover transcatheter valve news announced at ACC, Covidien's brain aneurysm device, NMT Medical closing shop, J&J's move to acquire Synthes and VisualSonics in vivo imaging technology for cancer.
Market & Industry Briefs
Brief summaries of recent medtech market and industry developments. This month we cover transcatheter valve news announced at ACC, Covidien's brain aneurysm device, NMT Medical closing shop, J&J's move to acquire Synthes and VisualSonics in vivo imaging technology for cancer.
Radiosurgery Branches Out
The convergence of advancing technology and the push for more effective, noninvasive cancer treatments is helping to build the perfect storm of innovation for the field of stereotactic radiosurgery. SRS allows high doses of precisely focused ablative energy to be delivered to targeted tissues with a minimum of damage to surrounding areas. It has been used for years to treat tumors in the head and neck, where patient movement can be effectively restrained with frames to protect healthy tissue. However, technological advances are now making the procedure more viable for tumors in other parts of the body, and that opens the door to treating cancers in the lung, prostate, breast, and beyond.